NORDIC BIOSITE ApS: Financial statements 2024
CVR: 30711572
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
NORDIC BIOSITE ApS (CVR 30711572) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 6,582,661 and a net result of DKK 1,205,660 compared with DKK 2,466,842 the year before. That is an increase of 49.2% compared with the year before. Equity in the 2024 report amounted to DKK 2,088,088. The solvency ratio was 49.8%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 6,582,661
- Profit/Loss
- DKK 1,205,660
- Equity
- DKK 2,088,088
- Total Assets
- DKK 4,190,072
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 6.6M | 1.2M | 2.1M | 3 |
| 2023 | - | 4.4M | 2.5M | 3.4M | 2 |
| 2022 | - | 4.1M | 1.8M | 2.4M | 2 |
| 2021 | - | 4.1M | 1.2M | 2.4M | 3 |
| 2020 | - | 14.5M | 9.3M | 9.7M | 3 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of May 31, 2024, John Philip Bergquist has joined the board of directors of NORDIC BIOSITE ApS.
As of May 31, 2024, Lars Olof Erhard Gisterå has left the board of directors of NORDIC BIOSITE ApS.
NORDIC BIOSITE ApS has published its annual report for 2023. Gross profit came to DKK 4,413,028, and the net result was DKK 2,466,842.
About NORDIC BIOSITE ApS
NORDIC BIOSITE ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2007. The company is registered under the industry Aktiviteter inden for hospitalsvæsen. The management consists of Rasmus Valdemar Lind. The board consists of Rasmus Valdemar Lind (chair) and Claudia Maria Carolina Berron Osorno. The company is owned by Nordic Biosite AB. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 6,639,125 and a net result of DKK 1,220,258 compared with DKK 1,205,660 the year before. Equity in the 2025 report amounted to DKK 1,808,346.